A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.

Navar AM, Mikhailova E, Catapano AL, Banka P, Blom DJ, Cadena A, Kourpanidis S, Lepor NE, Tsukamoto K, Mendizabal G, Nunez J, Zhang W, Zhu P, Zhuo M, Ballantyne CM, CORALreef Lipids Investigators.

Open source

DOI: 10.1056/nejmoa2511002
Published: 2026-02-01
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2511002,
  title = {A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.},
  author = {Navar AM and  Mikhailova E and  Catapano AL and  Banka P and  Blom DJ and  Cadena A and  Kourpanidis S and  Lepor NE and  Tsukamoto K and  Mendizabal G and  Nunez J and  Zhang W and  Zhu P and  Zhuo M and  Ballantyne CM and  CORALreef Lipids Investigators.},
  year = {2026},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2511002},
  url = {https://doi.org/10.1056/nejmoa2511002}
}

RIS

TY  - JOUR
TI  - A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
AU  - Navar AM
AU  -  Mikhailova E
AU  -  Catapano AL
AU  -  Banka P
AU  -  Blom DJ
AU  -  Cadena A
AU  -  Kourpanidis S
AU  -  Lepor NE
AU  -  Tsukamoto K
AU  -  Mendizabal G
AU  -  Nunez J
AU  -  Zhang W
AU  -  Zhu P
AU  -  Zhuo M
AU  -  Ballantyne CM
AU  -  CORALreef Lipids Investigators.
PY  - 2026
JO  - N Engl J Med
DO  - 10.1056/nejmoa2511002
UR  - https://doi.org/10.1056/nejmoa2511002
ER  -

APA

AM, N., E, M., AL, C., P, B., DJ, B., A, C., S, K., NE, L., K, T., G, M., J, N., W, Z., P, Z., M, Z., CM, B., & Investigators., C. L. (2026). A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.. N Engl J Med. https://doi.org/10.1056/nejmoa2511002

Source records

europe-pmc · retrieved 2026-09-26T03:40:42.851Z